parametric apparent diffusion coefficient maps (Kiromic LLC)
90
Structured Review
Kiromic LLC
parametric apparent diffusion coefficient maps
Parametric Apparent Diffusion Coefficient Maps, supplied by Kiromic LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apparent+diffusion+coefficient+maps/parametric+apparent+diffusion+coefficient+maps/pm32002663-28-72-62
Average 90 stars, based on 1 article reviews
Parametric Apparent Diffusion Coefficient Maps, supplied by Kiromic LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/apparent+diffusion+coefficient+maps/parametric+apparent+diffusion+coefficient+maps/pm32002663-28-72-62
Average 90 stars, based on 1 article reviews
parametric apparent diffusion coefficient maps - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Diffusion-based Assay:Article Title: PD-L1, fibrosis, and immunotherapy in hepatocellular carcinoma: the importance of a scientific method to explore observations and answer questions. Article Snippet: In light of promising data demonstrating a restoration of host immunity against tumors after inhibition, the PD-1/PD-L1 axis has become a topic of particular interest.. Determining which patients derive benefit from PD-1/PD-L1-directed immunotherapy remains, however, an important clinical question, particularly in light of the reported broad spectrum of toxicity of these agents.. In a recent edition of Surgery Today, Elmezayen et al. [1] reported that PD-L1-expressing cells in the background liver, but not in the tumor tissue, appeared to contribute to the serum PD-L1 (sPDL1) level, suggesting that sPDL1 was not indicative of the tumor burden in patients with hepatocellular carcinoma (HCC). Activity Assay:Article Title: PD-L1, fibrosis, and immunotherapy in hepatocellular carcinoma: the importance of a scientific method to explore observations and answer questions. Article Snippet: In light of promising data demonstrating a restoration of host immunity against tumors after inhibition, the PD-1/PD-L1 axis has become a topic of particular interest.. Determining which patients derive benefit from PD-1/PD-L1-directed immunotherapy remains, however, an important clinical question, particularly in light of the reported broad spectrum of toxicity of these agents.. In a recent edition of Surgery Today, Elmezayen et al. [1] reported that PD-L1-expressing cells in the background liver, but not in the tumor tissue, appeared to contribute to the serum PD-L1 (sPDL1) level, suggesting that sPDL1 was not indicative of the tumor burden in patients with hepatocellular carcinoma (HCC). |
![FIGURE 2 (A) Representative images obtained in one rat at 3 h following the MCAo. The <t>ADC</t> map depicts the core of ischemia (arrow). The time-to-peak map reveals a larger zone of hypoperfusion (arrow). The penumbra was delineated as the mismatch between perfusion and diffusion abnormalities (hatched purple). The StO2-MRI map shows the area with reduced oxygen saturation (arrow). [18F]-FMISO-PET delineates the hypoxic area with increased retention of [18F]-FMISO (arrow). The T2-W image, acquired 24 h after the MCAo, shows the consolidated lesion (arrow). (B) Evolution of ADC-defined lesion volumes. The lesion demonstrable at 15 min expanded at 3 h, and even more so at 24 h following the MCAo. **p < 0.01; ***p < 0.001; ANOVA with repeated measures followed by Tukey's post hoc test. The boxes define the interquartile range; the solid horizontal line the median, and the whiskers represent the minimal and maximal values. (C) Volumes of brain compartments at 3 h following the MCAo. Time-to-peak (TTP): tissue volume with decreased perfusion; Penumbra: tissue with PWI/DWI mismatch; StO2-MRI: tissue that displays a decrease in oxygen saturation; [18F]-FMISO-PET: tissue volume that shows an increased retention of [18F]-FMISO. The boxes define the interquartile range; the solid horizontal line the median and the whiskers represent the minimal and maximal values. ADC, apparent diffusion <t>coefficient;</t> ANOVA, analysis of variance; DWI, diffusion-weighted imaging; MCAo, middle cerebral artery occlusion; PET, positron emission tomography; PWI, perfusion-weighted imaging; StO2-MRI, magnetic resonance-based imaging of brain oxygen saturation; T2-W, T2-weighted; [18F]-FMISO, 18-fluorine-fluoromisonidazole](https://pub-med-unpaywalled-images-cdn.bioz.com/pub_med_ids_ending_with_5719/pm36285719/pm36285719__page5_image1.jpg)
![FIGURE 5 Representative images of StO2-MRI, [18F]-FMISO-PET, and the superimposition of both abnormalities on the ADC image for each animal. StO2-MRI abnormality is delinated in yellow and [18F]-FMISO-PET abnormality in green. ADC, apparent diffusion coefficient; [18F]-FMISO, 18-fluorine-fluoromisonidazole; PET, positron emission tomography; StO2-MRI, magnetic resonance-based imaging of brain oxygen saturation; SUV, standardized uptake value](https://pub-med-unpaywalled-images-cdn.bioz.com/pub_med_ids_ending_with_5719/pm36285719/pm36285719__page8_image1.jpg)